Monday evening, we had another new SPAC IPO filing, this time from serial SPAC issuer Daniel Hennessy. Hennessy Capital Acquisition Corp. IV (HCACU), will be focusing on industrial, infrastructure solutions and value-added distribution sectors in the United States and plans to raise $250 million. The eponymous Daniel J. Hennessy, will be leading as Chairman and CEO, while Greg Ethridge (most recently, President of Matlin & Partners Acquisition Corp.), will be in the role of President and COO.
For reference, below is a table showing the first three Hennessy SPACs and their business combinations.
| Size (mms) | Target | Symbol | Current Share Price |
|
|---|---|---|---|---|
| Hennessy I | $100 | Blue Bird Corp. | BLBD | $18.01 |
| Hennessy II | $175 | Daseke, Inc. | DSKE | $4.36 |
| Hennessy III | $225 | NRC Group Holdings Corp. | NRCG | $9.21 |
Looking at this SPAC’s structure (scroll down), we have a lot of “extras”. We see an Anchor Investor (Blackrock for $32.5M), a Forward Purchase (Nomura for $125M), and the Crescent Term to boot (threshold of $9.20). However, you will also notice that this is a 101% in trust deal ($10.10 per share) and there is 3/4 warrant included in the unit. Plus, it has an 18-month life. Notably, these terms are nearly the same exact terms Hennessy III went out with and it appears that is what the Hennessy team is most comfortable marketing. (For reference, I looked up Hennessy III and their terms were: 18 months, 101% and 3/4 warrant, but no Forward Purchase or Anchor Investor.)
However, Hennessy III used Credit Suisse and Stifel as their underwriters, whereas Hennessy IV is using Nomura, Stifel and I-Bankers. This is Stifel’s second appearance on a SPAC this year, having recently been an underwriter in the RMG Acquisition Corp. deal. But the real surprise was Nomura. This is Nomura’s first SPAC as an underwriter, so we’ve got another competitor for the League Tables this year!
All told, these terms are sell-able. The 3/4 of a warrant always seems a little wonky, mostly because we are creatures of habit and have gotten so used to using the standard 1, 1/2 or a 1/3 that you throw a 3/4 in there and you actually have to think about it now. But hey, whatever sells…
Summary of terms below:
Nomura and Stifel are joint book-running managers. I-Bankers Securities, Inc. is co-manager.
Ellenoff Grossman & Schole LLP and Skadden, Arps, Slate, Meagher & Flom LLP are issuer’s counsel and underwriter’s counsel, respectively.
SPACInsider 2024 Awards 2024 was clearly a rebuilding year for SPACs and the pace didn’t really gather momentum until June. But in typical SPAC fashion, once the market catches fire, it builds very, very quickly. With that being said, there are some noteworthy standouts this year that are worth highlighting. As such, this is the...
At the SPAC of Dawn (UPDATED) It was a slow start to the day after the Christmas holiday, especially because the SEC was “experiencing technical difficulties” this morning. That makes for a slow news day. Other than that, we hope everyone had a great holiday and is easing back into the work flow. Deals and...
Aimei Health Technology II Co., Ltd (NASDAQ:AHJKU) has filed for a $60 million SPAC ostensibly to pair up with a small cap biotech or medical device target, but its team’s experience both in SPACs and beyond suggest the vehicle will be open to a broad set of potential targets. It is the first SPAC to...
At the SPAC of Dawn The markets got to open one stocking early yesterday, but it was mostly coal as it showed durable goods orders had declined by more than twice as much as expected to -1.1% in November. It wasn’t all signs of naughtiness, however. Amid the numbers that came public one day earlier...
Copley Acquisition Corp has filed to raise a $150 million SPAC to hunt for a technology or lifestyle target in either the Asia Pacific or North America regions. The new S-1 also advances underwriter Clear Street in the league tables as it has backed two of the three latest SPACs to file in December, and...